Table 1. Age-Adjusted Prevalence
a and Adjusted Prevalence Ratio
b of Sleep Disorder Symptoms Among Adults in 8 States
c and the District of Columbia, 2017 Behavioral Risk Factor Surveillance System
Characteristic |
Number of respondents |
Trouble falling asleep or staying asleepd |
Unintentionally falling asleepe |
Unweighted, n |
Prevalence (95% CI)a |
Prevalence ratio (95% CI)b |
Prevalence (95% CI)a |
Prevalence ratio (95% CI)b |
Crude percentage |
59,108 |
49.1 (48.4–49.8) |
NA |
24.0 (23.4–24.5) |
NA |
Age-adjusted percentage |
59,108 |
49.5 (48.8–50.2) |
23.1 (22.5–23.7) |
Sex |
Male |
27,657 |
43.8 (42.8–44.8) |
0.80 (0.78–0.83) |
23.0 (22.2–23.8) |
1.05 (0.99–1.10) |
Female |
31,451 |
55.3 (54.3–56.3) |
1.0 [Reference] |
23.4 (22.5–24.2) |
1.0 [Reference] |
Age group, y |
18–44 |
16,150 |
52.0 (50.8–53.1) |
1.0 [Reference] |
21.2 (20.2–22.1) |
1.0 [Reference] |
45–64 |
21,861 |
50.4 (49.3–51.4) |
0.94 (0.91–0.98) |
21.3 (20.4–22.2) |
0.98 (0.92–1.05) |
≥65 |
21,097 |
41.6 (40.5–42.6) |
0.76 (0.73–0.80) |
33.4 (32.4–34.4) |
1.60 (1.49–1.72) |
Race and ethnicity |
Non-Hispanic White |
48,909 |
51.2 (50.4–52.0) |
1.0 [Reference] |
21.1 (20.5–21.7) |
1.0 [Reference] |
Non-Hispanic Black |
3,426 |
44.6 (41.3–47.8) |
0.78 (0.72–0.85) |
32.8 (29.9–35.9) |
1.40 (1.26–1.56) |
Hispanic |
3,612 |
41.9 (39.8–44.1) |
0.86 (0.81–0.91) |
23.8 (22.0–25.6) |
1.20 (1.11–1.31) |
Other non-Hispanicf |
3,161 |
49.6 (46.7–52.4) |
0.93 (0.87–1.00) |
28.7 (26.2–31.4) |
1.36 (1.23–1.51) |
Marital status |
Married or member of an unmarried couple |
33,627 |
47.0 (45.9–48.1) |
1.0 [Reference] |
20.3 (19.4–21.2) |
1.0 [Reference] |
Divorced, widowed, or separated |
15,889 |
52.1 (48.8–55.4) |
1.04 (1.01–1.08) |
26.6 (24.1–29.2) |
1.19 (1.12–1.26) |
Never married |
9,592 |
53.8 (52.0–55.6) |
1.21 (1.17–1.26) |
27.0 (25.4–28.7) |
1.43 (1.33–1.53) |
Body mass index (kg/m2) |
Underweight or normal weight (<25.0) |
19,034 |
49.7 (48.5–50.9) |
1.0 [Reference] |
19.8 (18.9–20.8) |
1.0 [Reference] |
Overweight (25.0–29.9) |
21,549 |
47.0 (45.8–48.3) |
0.97 (0.93–1.00) |
21.3 (20.4–22.4) |
1.02 (0.96–1.09) |
Obese (≥30.0) |
18,525 |
52.5 (51.2–53.8) |
0.97 (0.94–1.01) |
28.4 (27.2–29.5) |
1.23 (1.15–1.31) |
Selected chronic diseaseg |
Yes |
31,010 |
58.3 (57.0–59.5) |
1.19 (1.15–1.23) |
29.0 (27.9–30.2) |
1.40 (1.33–1.48) |
No |
28,098 |
43.3 (42.4–44.1) |
1.0 [Reference] |
18.2 (17.5–18.9) |
1.0 [Reference] |
High blood pressure |
Yes |
22,946 |
57.2 (55.3–59.0) |
1.09 (1.06–1.13) |
29.2 (27.4–31.0) |
1.16 (1.09–1.22) |
No |
36,037 |
47.2 (46.4–48.0) |
1.0 [Reference] |
20.6 (19.9–21.2) |
1.0 [Reference] |
Depression |
Yes |
11,704 |
72.2 (70.9–73.5) |
1.54 (1.50–1.58) |
31.5 (30.2–32.9) |
1.35 (1.28–1.43) |
No |
47,187 |
43.3 (42.5–44.1) |
1.0 [Reference] |
20.8 (20.1–21.4) |
1.0 [Reference] |
Average sleep duration in a 24-hour period, h |
<7 |
18,054 |
62.1 (60.9–63.3) |
1.44 (1.40–1.48) |
29.1 (28.0–30.2) |
1.39 (1.32–1.46) |
7–9 |
39,012 |
42.7 (41.8–43.6) |
1.0 [Reference] |
19.3 (18.6–20.0) |
1.0 [Reference] |
>9 |
2,042 |
50.1 (45.4–54.8) |
1.01 (0.92–1.11) |
32.1 (28.0–36.5) |
1.32 (1.15–1.50) |
Abbreviation: NA, not applicable.
aAge-adjusted prevalence and 95% CIs were standardized to the 2000 projected US population for all selected characteristics except for age group.
bAdjusted prevalence ratio was obtained from multivariable logistic regression models with all covariates in the table.
cEight states are Arizona, Kansas, Minnesota, Nebraska, Nevada, North Dakota, Oregon, and Tennessee.
dTrouble falling asleep or staying asleep was defined as a respondent reporting ≥1 day of trouble falling asleep or staying asleep or sleeping too much in the past 14 days.
eUnintentionally falling asleep was defined as a respondent reporting ≥1 day of unintentionally falling asleep in the past 14 days.
fOther, non-Hispanic includes non-Hispanic American Indian or Alaskan Native, non-Hispanic Asian, non-Hispanic Native Hawaiian or Pacific Islander, non-Hispanic other race, and non-Hispanic multiracial.
gChronic diseases include heart disease (coronary heart disease/angina, myocardial infarction/heart attack), stroke, diabetes, arthritis, history of asthma, chronic obstructive pulmonary disease, cancer (not including skin cancer), and chronic kidney disease.